bullish
Mayne Pharma (MYX AU): This Is A Buy
611 Views22 Apr 2025 16:09
Mayne has revised the Scheme timeline, with completion targeted late June, early July. This is done. Trading at a 5.1%/27.1% gross/annualised spread, assuming first week of July payment.
What is covered in the Full Insight:
- Introduction to the Mayne Pharma Deal
- Financial Performance and Future Outlook
- Impact of Pending Lawsuit
- Scheme Terms and Shareholder Support
- External Factors and Market Conditions
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
x